IntellaTurn’s email newsletters deliver unbiased and timely business-critical information to smart, busy biopharma professionals.

We include a clear headline, summarize the main points, give context, and provide the option to “go deeper” and learn more.

We offer three subscription tiers:

Our free newsletter with headlines impacting the biopharma industry at large

Weekly

IntellaTurn’s Weekly Scoop PLUS rapidly evolving FDA and HHS regulatory and policy topics

Weekly

A reduced rate is available for
small teams of up to 5 employees

Regulatory TrendWatch PLUS curated headlines relevant to your company’s unique focus

Daily, weekly, or twice-monthly

Includes option for ad-hoc research services

Direct to your inbox, as a succinct e-newsletter digest.
The newsletter is designed with an engaging and dynamic format optimized for both desktop and mobile devices.

No; distribution is to an unlimited number of recipients, including employees, consultants, and board members.

Regulatory TrendWatch is issued on a weekly basis.
Curated and Therapy Area News is available on a daily, weekly, or twice-monthly basis, depending on your company’s specific needs.

A PDF archive hosted on a secure webpage is included with every Curated and Therapy Area News tiered subscription.

For Curated and Therapy Area News tiered subscriptions, we will alert you ASAP with news flashes for pre-specified essential topics, such as competitor data releases, FDA guidances, and late-breaker conference abstracts.

Our support varies from single-scope projects to customized retainer agreements.
Email us to learn about how we can help your company turn information into intelligence.